Protection by GDNF and other trophic factors against the dopamine-depleting effects of neurotoxic doses of methamphetamine.
about
Neurotrophic factors as a therapeutic target for Parkinson's diseaseMethamphetamine preconditioning alters midbrain transcriptional responses to methamphetamine-induced injury in the rat striatumGlial cell line-derived neurotrophic factor (GDNF) as a novel candidate gene of anxietyRecombinant AAV8-mediated intrastriatal gene delivery of CDNF protects rats against methamphetamine neurotoxicityThe glial cell modulator and phosphodiesterase inhibitor, AV411 (ibudilast), attenuates prime- and stress-induced methamphetamine relapse.The TrkB-positive dopaminergic neurons are less sensitive to MPTP insult in the substantia nigra of adult C57/BL mice.Amphetamine toxicities: classical and emerging mechanisms.Neurotoxic (+)-methamphetamine treatment in rats increases brain-derived neurotrophic factor and tropomyosin receptor kinase B expression in multiple brain regionsMethamphetamine preconditioning causes differential changes in striatal transcriptional responses to large doses of the drug.Impact of methamphetamine on dopamine neurons in primates is dependent on age: implications for development of Parkinson's disease.Gender, brain-derived neurotrophic factor Val66Met, and frequency of methamphetamine useGlial cell-line derived neurotrophic factor (GDNF) replacement attenuates motor impairments and nigrostriatal dopamine deficits in 12-month-old mice with a partial deletion of GDNFHarpagoside attenuates MPTP/MPP⁺ induced dopaminergic neurodegeneration and movement disorder via elevating glial cell line-derived neurotrophic factor.Exceptional stability of artemin neurotrophic factor dimers: effects of temperature, pH, buffer and storage conditions on protein integrity and activity.Enhanced dopamine transporter activity in middle-aged Gdnf heterozygous mice.Role of glial cell derived neurotrophic factor in the protective effect of smilagenin on rat mesencephalic dopaminergic neurons damaged by MPP+.Dose-Dependent Effects of Binge-Like Methamphetamine Dosing on Dopamine and Neurotrophin Levels in Rat Brain.
P2860
Q28273071-1F215E5E-2C03-4F4A-9175-7383C7C46002Q28471860-FD422273-EC7B-4F85-88F8-4B52DA01B617Q28536350-5EB1757B-12FF-4E74-8187-F0596881B89FQ33702977-B791B8DE-96DE-4A68-9496-1A65CEE671E6Q33886313-89E5337D-F129-4134-B22B-BCDBB815AAA7Q33896035-88F226D1-259D-425E-AB87-FDF8B45B9B9DQ34102002-EE4BB7C1-50E8-4FD3-AF4D-5FC62D8327DEQ35000414-430E6823-E467-4443-9C66-6E285077ACC2Q35056078-0536CD6D-0A4A-4B4A-B976-3B6BA91C4F42Q35147689-DBBAB854-7240-46B5-A273-89F37C499970Q35877933-3EAE16CD-94B6-43B7-8A4E-7FCAC53FFA1AQ39216202-349D96DB-27D6-4E5C-849D-6A93B61FDE4CQ39423921-9307C708-3929-4966-8E91-89FA8292B005Q39479471-14066AC7-322A-47AB-9FB8-D45F04C4A329Q39622221-E7B40AFE-5D8A-4057-837D-A7A08D00604FQ40009062-EA1FF965-0762-4EC6-9709-00159B9A6B11Q47609902-BE1412EB-48CF-4AE9-B9B8-75ED0E0F3358
P2860
Protection by GDNF and other trophic factors against the dopamine-depleting effects of neurotoxic doses of methamphetamine.
description
2006 nî lūn-bûn
@nan
2006年の論文
@ja
2006年論文
@yue
2006年論文
@zh-hant
2006年論文
@zh-hk
2006年論文
@zh-mo
2006年論文
@zh-tw
2006年论文
@wuu
2006年论文
@zh
2006年论文
@zh-cn
name
Protection by GDNF and other t ...... oxic doses of methamphetamine.
@en
type
label
Protection by GDNF and other t ...... oxic doses of methamphetamine.
@en
prefLabel
Protection by GDNF and other t ...... oxic doses of methamphetamine.
@en
P2093
P2860
P356
P1476
Protection by GDNF and other t ...... oxic doses of methamphetamine.
@en
P2093
Kim B Seroogy
Laura E Peters
Michael E Harned
Wayne A Cass
P2860
P304
P356
10.1196/ANNALS.1369.024
P407
P577
2006-08-01T00:00:00Z